Cargando…
Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy
Interim (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (I-PET/CT) is a powerful tool for monitoring the response to therapy in diffuse large B-cell lymphoma (DLBCL). This retrospective study aimed to determine when and how to use I-PET/CT in DLBCL. A total of 197 pat...
Autores principales: | Zhang, Xu, Fan, Wei, Xia, Zhong-Jun, Hu, Ying-Ying, Lin, Xiao-Ping, Zhang, Ya-Rui, Li, Zhi-Ming, Liang, Pei-Yan, Li, Yuan-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360075/ https://www.ncbi.nlm.nih.gov/pubmed/25418196 http://dx.doi.org/10.5732/cjc.014.10124 |
Ejemplares similares
-
Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
por: Cheah, C Y, et al.
Publicado: (2013) -
Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance
por: Suh, Koung Jin, et al.
Publicado: (2019) -
The Impact of First Complete Remission by PET-CT and Time to Next Treatment on Survival of Follicular Lymphoma Patients
por: Tan, Tran-Der, et al.
Publicado: (2019) -
Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission
por: Nishida, Hiroko, et al.
Publicado: (2018) -
Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma
por: Zhang, Xu, et al.
Publicado: (2015)